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1. Introduction
Postoperative care of thoracic surgical patients is a very important part of patient recovery and
can be very challenging. Pulmonary complications are responsible for significant numbers of
deaths and morbidity of patients undergoing thoracotomy. Thoracic surgery impairs postop‐
erative respiratory function resulting in a relatively high risk of developing postoperative
pulmonary complications. The incidence (19-59%) is much higher than following upper
(16-17%) or lower abdominal surgery (0-5%). The overall incidence of complications following
thoracic surgery varies from 15% to 37.5%, primarily due to the type of pulmonary complica‐
tions studied, the clinical criteria used in the definition and the type of surgery included. The
clinical and potential economic impact of these complications is marked, with significantly
longer hospital and high Dependency unit stay, frequency of ICU admission and number of
deaths.
A centre can achieve excellent results by concentrating on the basics of postoperative care like
pulmonary hygiene and physiotherapy, fluid and pain management and management of
pleural spaces. Risk factors for complications following thoracic surgery have been identified
from numerous clinical studies using a variety of research designs and definitions. The most
frequent risk factors include age, preoperative pulmonary function tests, cardiovascular co
morbidity, smoking status and chronic obstructive pulmonary disease (COPD). [1]- [4] In the
current era there has to be more emphasis on postoperative care due to the complexity of
referrals with the thoracic units doing more patients with multiple risk factors for post
operative complications. This gets more challenging with cost containment.
High-risk patients can be optimised with preoperative and postoperative cardiopulmonary
rehabilitation to reduce their operative risk, frequency of complications and hospital stay and
improve postoperative outcomes including postoperative lung function. [5], [6] In addition,
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preoperative pulmonary rehabilitation may improve preoperative exercise capacity and so
operability. [7], [8] The future development and adoption of innovative strategies is required
to reduce the impact of post operative complications in an ageing co morbid population.
In this section will cover the routine care of a postoperative thoracic patient with specific
emphasis on prevention and management of common complications.
2. Preoperative optimisation of specific risk factors
The outcome of surgical procedures is not measured only by clinical end points but also shorter
stays and lower costs [9]. Patients’ discharge is delayed commonly due to inadequate pain
relief, infection, arrhythmias, prolonged air leak and debility [9]. Many complications that
occur from thoracic operations can be anticipated. An aggressive preoperative work up
mitigates morbidity and shortens convalescence.
2.1. Smoking
Preoperative cessation of smoking prevents postoperative complications to a large extent.
Support groups, counselling and nicotine replacement therapy should be used [10]. Histori‐
cally, 6 weeks of smoking cessation before surgery is recommended to avoid the copious
bronchorrhea that accompanies regeneration of the cilia that clear mucus between 2 and 4
weeks after smoking cessation [11].there are few studies which challenge this challenge this
notion of timing of smoking cessation. Even 3-5 days of stopping could improve clearance and
decrease of secretions. Vaporciyan el al showed that patients who quit smoking 4 weeks or
more before surgery had a lower incidence of pulmonary complications than patients who
continued to smoke or quit fewer than 4 weeks before pneumonectomy [12]. However, Barrera
and co-workers found no difference in the incidence of pulmonary complications between
patients who were still smoking at the time of surgery and those who had quit fewer than 2
months before thoracotomy for lung resection [13]. In many centres including ours the
recommendation is to stop smoking at any time and provide support services to help out with
the same.
2.2. Preoperative education and physiotherapy
Preoperative physiotherapy and education is done in many centres as part of work up for
thoracotomy. Physiotherapists and thoracic ward medical and other staff perform a variety of
care for patients undergoing surgery both pre and post operatively. All these are done to
prevent postoperative complications like atelectasis, pneumonia, effusions and empyema.
Various manoeuvres include education, deep breathing and coughing manoeuvres, chest
physiotherapy and early mobilization education post sugery [14]. According to few studies
this has led to an improvement in the prevention of atelectasis, collapse and consolidation.
Many other interventions like incentive spirometry and respiratory muscle strengthening have
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been shown to reduce the incidence of these complications. During the work up assessment
of the pulmonary functions are done and bronchodilators optimised.
In the education session instructions may be given for deep breathing and splinted coughing
exercises, prophylaxis exercises for deep vein thrombosis, and shoulder exercises [15]. There
studies which question the benefit of preoperative education and physiotherapy and few
studies have shown them to be non-beneficial16 but we continue to follow preoperative
education as well as physiotherapy prior to thoracic surgery.
Patients are also investigated for cardiac ailments if there are symptoms, signs or significant
cardiac history prior to performing elective thoracic surgery. Investigations may include
echocardiography, cardiac viability study or angiogram. Patients who are on antiplatelets
should have their medications withheld 7 days prior to surgery is possible. If patients are on
warfarin then it is stopped 3 days prior to surgery and are covered with heparin
Patients are given a single dose of antibiotics for elective cases and they are continued for
infected cased or restarted postoperatively if needed. If surgical intervention is elective, we
advocate a short period of preparation may be beneficial if directed at improving the patient's
physical status and specifically at pulmonary preparation, conditioning exercises, and
nutrition.
3. Operative factors
3.1. VATS vs. OPEN
Video assisted Thoracoscopic procedures are done with increasing frequency for many
indications. The incidence of postoperative complications is 9% after VATS and they include
haemorrhage, empyema, air leak, pneumonia and surgical emphysema [17] commonly but
most of the complications which happen in thoracotomy could potentially happen with video
assisted Thoracoscopic procedures.
Most importantly the incidence of postoperative pain is much less in VATS than open
procedures and they have shorter hospital stay. The proponents of VATS have published many
series about the feasibility, lesser complication rate, reduced pain, early mobility and discharge
[18], [19]. There are groups who did not find any statistical benefit in performing VATS and
have quoted a higher bleeding and intraoperative complication rate [20]. In our unit we
perform VATS for all kinds of thoracic procedures if patients are suitable for it. VATS lobec‐
tomy is a safe procedure, which reduces peri operative pain and improves postoperative
physical status. The results obtained with early stage lung cancer are excellent and may reflect
inherent oncologic advantageous consequent upon reduced operative trauma. Detection of
early stage lung cancer is potentially rewarding and will become a practical imperative if
survival results are to be improved. Thus the scope for VATS resection may increase signifi‐
cantly. In our view VATS lobectomy is the procedure of choice for early stage lung cancer and
multicentre prospective randomised trials comparing this therapy against conventional open
resection are overdue.
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3.2. Use of staplers and glues to reduce and seal air leaks
Various procedures like wedge resections, lobectomies, excision of bullae may cause pro‐
longed air leaks especially if patients have COAD. Traditionally diathermy dissection and
ligation was used and later staplers were used for parenchymal resections. Although certain
studies pointed towards improved results with regards to air leaks using staplers [21] and
reported that surgical morbidity due to air leaks decreased with this technique other studies
have not shown any particular reduction in duration of air leaks using staplers alone. [22]
The air leaks caused by the holes of the suture needles are of the same magnitude as that caused
by the surface tension between the parallel staple lines when the lung inflates. Nevertheless
staplers are quicker to use and they have a big role in minimally invasive Thoracoscopic
procedures
Polyglycolic acid fabric, polydioxan ribbon, bovine pericardial strips, bovine collagen, and
recently, expanded polytetrafluoroethylene have been employed in an attempt to reinforce the
staple lines, especially for resections performed in emphysematous lungs [23]- [27]. Other
techniques like the electrothermal bipolar sealing have shown good results in lung parenchy‐
mal surgery.
Air leaks are common after pulmonary resections. They can be inspiratory, expiratory,
continuous and forced expiratory. Most of the leaks are expiratory or forced expiratory.
Inspiratory leaks happen on positive pressure ventilation. If there is no pleural space then they
are managed by underwater seal. If there is a space negative suctions is applied to the
underwater seal. If the leak persists beyond a particular time frame then TALC or reopening
should be considered.
4. Post operative care
4.1. Pain management
Pain management is of paramount importance post operatively as it is essential for patients to
comply for chest physiotherapy and ambulation and they will be unable to do so if they have
severe pain. There are various ways by which pain is managed. They include epidural catheters
preoperatively, paravertebral methods pre or intraoperatively or intravenous patient control‐
led analgesia. On withdrawing these agents patients will need oral analgesics for duration of
time till they are pain free. These include paracetamol, NSAID and narcotic agents.
4.1.1. Epidural analgesia
The catheter is placed approximately with the midpoint of the dermatomal distribution of the
skin incision. Epidural local anaesthetics increase segmental bioavailability of opioids in the
cerebrospinal fluid and increase the binding of opioids to m receptors and the blocking of the
release of substance P in the substantia gelatinosa of the dorsal horn of the spinal cord [28].
The thoracic segmental effects of local anaesthetic and opioid combinations is the only way to
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minimize motor and sympathetic blockade maintain conscious level and cough reflex and
reliably produce increased analgesia with movement and increased respiratory function after
thoracotomy [29]. Generally the most popular regimens are fentanyl or diamorphine combined
with levobupivacaine [29]. The regimens can be administered as an infusion, patient controlled
analgesia or both.
Potential issues include failure, technical difficulty and hypotension. It can also reduce the
effectiveness of coughing, especially in patients who already have a low FEV1. It is not offered
when there is local or systemic sepsis.
Paravertebral block is an effective modality to provide pain relief. It can be done by the
anaesthesiologist before the start of surgery or by the surgeon before closure. It offers several
technical and clinical advantages and is indicated for anaesthesia and analgesia when the
afferent pain input is predominantly unilateral from the chest and/or abdomen. We prefer
placing the catheter under direct vision during thoracic surgery and give pain relief as a
continuous infusion. The chest drain loss of local anaesthetic is four times lower than that of
interapleural block [30].
4.1.2 Systemic analgesics
Opioids remain the mainstay of postoperative analgesia and have demonstrated their efficacy
in the management of severe pain. The side effects include nausea, vomiting, ileus, biliary
spasms and respiratory depression, Opioids can be administered IM, subcutaneously, or IV.
A very efficient method of delivery of opioids is via PCA (Patient Controlled Analgesia)
devices. Numerous studies have demonstrated the safety and opioid-sparing effect of PCA.
After thoracic surgery PCA is often combined with other modalities to offer adequate pain
relief.
4.1.3. Intrapleural
Intrapleural local anaesthetics produce a multi-level intercostal block. However, the analgesia
is extremely dependent on patient position, infusion volume, and the type of surgery. With
the drains insitu most of the anaesthetic is drained out and hence the efficacy of the procedure
is less. In spite of occasional successes most clinicians have not found the reliability of
intrapleural techniques adequate to justify their use on a routine basis. [31]
4.1.4. Other techniques
Cryoanalgesia is the application of a -600ºC probe to the exposed intercostal nerves intra-
operatively produces an intercostal block that can persist for up to six months. This can be
moderately efficient to decrease post-operative pain, but is associated with an incidence of
chronic neuralgia that has lead many centres to abandon the technique [32]. Transcutaneous
electrical nerve stimulation (TENS) may be useful in mild to moderate pain but is ineffective
when pain is severe. [33]
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4.2. Management of fluid electrolytes
Patients are managed generally in a high dependency unit post surgery or the wards if it is a
dedicated thoracic unit. Post thoracic surgery especially in resections intravenous fluids are
given in reduced amounts to prevent pulmonary insufficiency. Care is taken not to overhydrate
the patient and oral feeding in encouraged as soon as possible. Intravenous fluids should be
used judiciously and a conservative strategy of administration of maintenance fluids is
recommended at 1–2 ml/kg/h in the intra- and post-operative periods and that a positive fluid
balance of 1.5 l should not be exceeded, to mitigate the risk of multifactorial post operative
acute lung injury/ARDS. Caution should be exercised with regard to silent hypovolaemia,
impaired oxygen delivery and acute kidney injury. A high index of suspicion for pulmonary
insufficiency should be adopted if there is volume overload. If a patient develops signs of hypo
perfusion after these thresholds are exceeded, inotropic/vasopressor support should be
considered. [34]
4.3. Intercostal catheter
Intercostal catheter is watched for drainage and air leak. If the postoperative chest X-ray shows
expanded lung fields the no suction is applied even if there is bubbling. If there is airspace the
suction is applied. It is preferable to use a balanced drainage system in all patients. In pneu‐
monectomy patients no suction is applied after surgery and the balanced drainage system is
filled with 1cm of liquid unlike routine thoracic cases where it is filled with 2 cm of fluid. In
pneumonectomy patients the drains are removed the next day and in lobectomy patients as
soon as possible. Suction is also applied in cases of pleurodesis with talc so that the visceral
and parietal pleurae are approximated. If the drains have to stay due to persistent minimal
bubbling and if the parenchyma is expanded without any suction a Heimlich valve container
is attached for earlier complete ambulation or discharge.
4.4. Physiotherapy and early mobilisation.
Postoperative insufficiency occurs because of infection, inability to clear secretions or oedema
around day 2 or 3, to prevent these from happening attention should be given to physiother‐
apy, bronchodilators, restriction of intravenous fluids and tracheal toilet. Chest physiotherapy
includes deep breathing and coughing exercises and incentive spirometry. Pulmonary
insufficiency is more common in patients have low FEV1. If there is inability to do so then
endotracheal suctioning or mini tracheostomy should be used for clearing secretions. Diuretics
are used if necessary and antibiotics are started if clinically indicated without waiting for
radiological deterioration.
Early postoperative ambulation and physiotherapy reduces complications like atelectasis,
pneumonia, empyema and DVT.
Aspiration should be prevented postoperatively as it can result in multiorgan dysfunction and
sepsis. Patients should be allowed to eat only when they are fully alert and sitting up. If there
is a tendency to aspirate patients are kept nil by mouth and nasogastric feeding initiated as
required. If there is damage to the vocal cords then a speech pathology is sought for and
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patients are initially kept on nasogastric feeds and based on recovery are put on graded diet
beginning from thickened fluids.
4.5. Deep Venous thrombosis prophylaxis
The prophylaxis should start when the patients are admitted in the hospital. Everyone should
be given a prophylactic dose of heparin subcutaneously if not contraindicated at a dose 5000
IU twice daily and this is continued in the postoperative period till discharge. All patients
should have stockings and the high-risk patients should be on compression stockings. If there
are signs of DVT then a Doppler in arranged and patients put in treatment dose of heparin
infusion and an IVC filter put in if necessary.
5. Complications
5.1. Postoperative haemorrhage
Immediate postoperative bleeding can be caused due to surgical bleeding or coagulopathy,
surgical bleeding being more common. A set of standard coagulation tests are performed and
coagulopathy is corrected accordingly. Depending on the coagulation profile factors like FFP,
Platelets, cryoprecipitate or factor 7 is given if the patient is bleeding due to profound coagul‐
opathy.The threshold for taking back a patient for re-exploration should be low, as a surgical
cause of bleeding should be ruled out. Bleeding after thoracic surgery is rare. It occurs in less
than 2% of video assisted Thoracoscopic procedures (VATS) and around 01% to 3% of open
procedures. [35]- [38] Generally postoperative bleeding results from technical complications,
but certain co morbidities may predispose a patient to bleeding. A chest tube output of 1000
ml in 1 hour necessitates an immediate return to the operating room with concurrent correction
of coagulopathy. Serial drainage exceeding 200 ml per hour for 2 to 4 hours after correction of
a coagulopathy also indicates surgical bleeding and dictates re-exploration. If the patient is
hemodynamic ally stable but the chest output is high, checking the haematocrit on the chest
tube drainage can be helpful in distinguishing active bleeding from a lymphatic leak. If a
patient in the immediate postoperative period is hemodynamically unstable but the chest tube
output does not suggest active haemorrhage, a chest radiograph may show radiopacity of the
operative side with thrombosed chest tubes. [40]
Medications like aspirin,  other antiplatelet  agents’  warfarin could cause increased bleed‐
ing  tendencies.  Several  herbs  like  garlic,  ginseng  etc.  effect  a  prolonged  bleeding  time,
which can result in peri operative haemorrhage. [39] The effect of herbal medications in
thoracic surgery specifically is lacking, but discontinuing herbs 2 weeks before a lung re‐
section is recommended. [40]
Recommendation for perioperative antiplatelet the current recommendations aim at providing
the best option for patients. There are issues regarding continuing or discontinuing these
medications. These recommendations are mainly form observational data. [41], [42], [43]
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In the current era Aspirin is a lifelong therapy and it is not necessary to stop it for surgery
when there are specific indications like prevention after stroke, acute coronary syndrome, MI,
or coronary revascularization, regardless of the time since the event that led to the recom‐
mendation of aspirin. [44]
Dual antiplatelet therapy is recommended during the two weeks after simple dilatation, six
weeks after bare-metal stents, and at least 12 months after drug-eluting stents. [41], [42], [43]
Elective operations should be postponed beyond these delays but most of the thoracic
procedures have to be done as soon as possible as a bulk of cases are due to malignancy hence
unless the hemorrhagic risk is excessive, dual antiplatelet therapy should not be interrupted
before surgery.
Even if clopidogrel treatment must be interrupted in high-risk surgical situations, aspirin must
be continued without interruption.41,42,43 Heparin has no antiplatelet activity and therefore
is not an adequate substitution for aspirin or clopidogrel treatment because stent thrombosis
is a platelet-mediated phenomenon. [42] Although not proven by any randomised controlled
trials bridging therapy with a short-acting platelet glycoprotein IIb/IIIa inhibitor like tirofiban
is a possible substitution for clopidogrel while aspirin is being maintained. [46] After the
operation, antiplatelet therapy is resumed within the first 12 to 24 hours; clopidogrel therapy
is reinitiated with a 300-mg loading dose, which reduces the time to achieve maximal platelet
inhibition to four to six hours and decreases the risk of hyporesponsiveness from competition
of other drugs with hepatic cytochromes.
Ticagrelor is used more often these days and should be stopped 36 to 48 hours prior to a
planned procedure. It is reversible P2Y12 adenosine disphosphate receptor binder with shorter
duration of action unlike clopidogrel which is irreversibly binds to it. The perioperative
management for it is similar to the clopidogrel.
Warfarin should be discontinued 3 days preoperatively, the INR checked. It should be
substituted with heparin and APTT checked.
Conversion to an open thoracotomy for control of bleeding is done in case of bleeding due to
VATS. Intraoperative bleeding can be massive from injury to the pulmonary artery or vein.
Proximal control of the pulmonary artery before dissection of its branches is a safe preventive
measure in open lobectomies. Rarely vascular stapler on a pulmonary vessel can cause
bleeding and so can its used in the parenchyma. Suturing of the lung is done to control
bleeding. Bleeding can also happen from peribronchial tissue, parenchyma, adhesions,
intercostal vessels, and muscles.
In some patients, postoperative bleeding develops that is not hemodynamically significant
enough to indicate re-exploration but results in a residual clotted hemothorax. As is true for a
posttraumatic clotted hemothorax, treatment options include VATS or open exploration and
evacuation of the hematoma to prevent development of a trapped lung, respiratory compro‐
mise, and empyema.
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5.2. Cardiac complications
Arrhythmia, more particularly atrial fibrillation (AF), is by far the most common cardiac
complication after thoracic surgery, with an incidence ranging from 10% to 20% after lobec‐
tomy and as much as 40% after pneumonectomy [46]- [47]
Risk factors for tachyarrhythmias include [48], patient related (pre-existing cardiovascular
disease, postural change, limited pulmonary reserve), surgery related (extensive procedure,
intrapericardial pneumonectomy, extra pleural pneumonectomy, anaesthetic agents, major
bleeding), treatment related (previous thoracic irradiation) or older age [47], [49]. The most
common arrhythmia encountered is supraventricular tachycardia.
If patients have atrial fibrillation with haemodynamic compromise then electrical cardiover‐
sion should be carries out immediately. If patients have sympromatic AF chemical cardiover‐
sion should be attempted first followed by electrical cardioversion if necessary. New-onset
postoperative AF is often transient and self-limiting and it is generally accepted that rate
comtrolling agents be given first. Rate control resolves AF in most cases in thoracic surgery.
AF generally resolves within 1 day of hospital discharge with rate control alone. [50]
A selective Beta 1-blocking agent is recommended as the initial drug for rate control in the
absence of moderate-severe chronic obstructive pulmonary disease or active bronchospasms
and Diltiazem should be the first agent used in the presence of moderate-severe chronic
obstructive pulmonary disease or active bronchospasm. [51]
Digoxin as a single agent should not be used for rate control, although it may be effective in
combination with a beta1-blocker or diltiazem. Beta blockers are considered better than
calcium channel blockers and digoxin for treating AF in thoracic surgery. The only concern is
COPD where it may cause bronchospasms specific beta 1 blockers such as metoprolol are
considered safer in this regard. [52]
When chemical cardioversion is employed in the setting of continuous or recurrent paroxysmal
postoperative AF, the most reasonable initial drugs are intravenous followed by oral amio‐
darone or oral flecainide. [51]
Amiodarone is not given if the patient has severe lung disease or if the patient as under‐
gone pneumonectomy The incidence of ARDS was 11% in the patients treated with amio‐
darone  and  1.8%  in  the  nonamiodarone  group  [53].  Flecainide  is  not  given  if  there  is
organic cardiac disease. Other drugs include disopyramide, ibutilide, procainamide, prop‐
afenone,  quinidine,  and  sotalol.  Patients  who  received  flecainide  had  an  approximately
doubled rate  of  mortality  or  cardiac  arrest,  likely  due  to  a  proarrhythmic  effect  on  the
ventricle  possibly  due  to  structural  heart  disease.  Side  effect  of  amiodarone  relevant  to
thoracic surgery is its pulmonary toxicity [51].
Both amiodarone and flecainide are highly effective and relatively safe drugs, but the specific
contraindications to their use must be kept in mind antiarrhythmic therapy is given usually
from 1 to 6 weeks. The only study that has evaluated optimal length of therapy with antiar‐
rhythmic drugs, once initiated, for postoperative AF (after coronary artery bypass graft
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surgery) found that there was no difference in the rate of recurrent AF whether the treatment
was continued for 1, 3, or 6 weeks after discharge. [54]
Anticoagulation Therapy For patients with two or more risk factors for stroke (age >75 years,
hypertension, impaired left ventricular function, prior stroke or transient ischemic attack) who
have postoperative AF that recurs or persists for more than 48 hours, anticoagulation therapy
is reasonable if not otherwise contraindicated. [51]
For patients with fewer than two risk factors for stroke and patients considered not suitable
for warfarin who have postoperative AF that recurs or persists for more than 48 hours, aspirin,
325 mg daily is recommended. [51]
Oral metoprolol initiated preoperatively and continued postoperatively decreased the
incidence of atrial fibrillation from 40% to 6.7% (p <0.05). [55] In another trial, administration
of magnesium sulphate starting the day of operative resection also resulted in a decrease in
the incidence of atrial fibrillation from 26.7% to 10.7. [56]
5.3. Ischemia
In a large series the incidence of ischemic electrocardiographic changes was 3.8% and myo‐
cardial infarction in 1.2%. According to this study hypotension and abnormal exercise testing
were the strongest predictors for ischemic events. [57]
Patients are monitored invasively, base line medication was continued, and peri operative
fluid administration was minimalized. We recommend continuous monitoring for at least 2
days in high-risk patient.
The American College of Cardiology and the American Heart Association guidelines [58] for
peri operative cardiovascular evaluation for no cardiac surgery remain the best available
method for risk assessment in noncardiac thoracic surgery. Thoracic surgery is categorized as
a high-risk surgical procedure in this matter. Coronary angiography is advocated in case of
major clinical predictors such as unstable angina, decompensated heart failure, significant
arrhythmias, or severe valvular disease. In cases of intermediate or minor clinical predictors
the decision whether to perform an angiography is based on non-invasive testing [59].
As adenosine and dipyridamole should be avoided in patients with clinical bronchospasms,
dobutamine stress echocardiography is the evaluation of choice for patients with cardiac
ischemia referred for thoracic surgery [60]. In general the indications for coronary angiography
are similar to those in the nonoperative setting. No prospective randomized data exists on the
role of prophylactic coronary bypass surgery. Whether percutaneous coronary intervention is
superior to bypass surgery is uncertain, but in cases of angioplasty with stenting it is probably
safer to postpone surgery for 2 to 4 weeks. In conclusion, the preoperative cardiac assessment
of thoracic surgery patients is of great importance, although prospectively controlled data for
this type of surgery are lacking. [59]
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5.4. Right-to-left shunt
It is estimated that 20% of the general population may have a persistently patent foramen
ovale  (PFO).  With the  increased right-sided pressures  associated with  pulmonary resec‐
tion, these patients can develop a right-to-left shunt with refractory hypoxia in the post‐
operative  period.  This  shunting  increases  most  dramatically  after  a  right
pneumonectomy. In some patients, symptoms may not present until after 1 to 5 months,
particularly after a right pneumonectomy. [61] Patients often present with dyspnoea (pla‐
typnea)  and  hypoxia  (orthodexia)  in  the  upright  position,  which  resolves  upon  recum‐
bence.  This  is  because  of  nediastinal  shift,  which modifies  the  relationship between the
right and left atrium and distorts the foramen ovale. Cardiac rotation and compression of
the right  atrium by pleural  fluid causes preferential  flow of  the inferior  caval  vein into
the left atrium. Hemodynamic factors may also have a role, such as reversal of the intera‐
trial  pressure  gradient.  A  decrease  in  right  ventricular  compliance  and  the  hydrostatic
pressures  in the left  lateral  decubitus  or  orthostatic  positions increase the shunt.  Lastly,
factors  such  as  pulmonary  emboli,  right  ventricular  infarction,  increased  intrathoracic
pressure,  chronic  obstructive  pulmonary  disease,  and  positive  pressure  ventilation  may
drive shunt physiology. [62] The aetiology of this complication is unclear.
The diagnosis is made with arterial blood gas analysis, nuclear lung perfusion scanning,
echocardiography, MRI, and cardiac catheterization or a combination thereof. Standard
treatment is surgical repair, although several cases of successful intravascular occlusion of the
septal defect have been performed.
Other causes of dyspnoea must be evaluated, including but not limited to pulmonary embo‐
lism, airway narrowing, and post resection pulmonary oedema.
5.5. Cardiac herniation
Cardiac herniation is a rare complication and happens in the early postoperative period.
Cardiovascular collapse is the presenting feature Jugular pulse is elevated and there can be
cyanosis in the drainage area of superior venacava. Ventricular fibrillation may occur [63].
Treatment is emergency thoracotomy with reposition of the herniated heart into the pericardial
sac and repairing the defect of the pericardium [64]. Most documented cases of cardiac
herniation have occurred through surgically created defects as a result of intrapericardial
pneumonectomy or lobectomy with partial pericardectomy [65]. Combination of a sudden
superior vena cava syndrome and heart sounds in the right side of the chest should alert the
physician to the possibility of cardiac herniation. Surgical defects of the pericardium as a result
of right intrapericardial pneumonectomy should be closed. This can be accomplished either
by suturing the cut edges of the pericardium to the epicardium or by patching the defect with
bovine pericardial patch, PTFE patch or parietal pleura. In cases of left pneumonectomy, it
may be sufficient to enlarge the pericardial defect in order to prevent strangulation, should
herniation occur [66].
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5.6. Heart failure
Few studies have addressed the problem of postoperative right ventricular dysfunction, which
is because of changes in right ventricular afterload and contractility [67]- [71]. Although right
ventricular end-diastolic volume remains stable in the early postoperative hours, significant
increases may be observed on the first and second postoperative days. Although many authors
[69]- [71] claim that afterload alteration is the major determinant of RV dysfunction. Pulmonary
artery pressure and pulmonary vascular resistance only rose modestly in a study [66],
suggesting that the rise in afterload is not the only causing factor. Another argument favouring
afterload augmentation as the cause of RV dysfunction is the fact that postoperative pulmonary
artery pressure, pulmonary vascular resistance, and central venous pressure only change
significantly during exercise [70]. Changes in RV function are able to compensate for the
increased RV end-diastolic volume at rest, but not during exercise, with a resultant increase
in pulmonary artery pressure and pulmonary vascular resistance. [59] One study used serially
performed transthoracic echocardiography to assess the effects of pulmonary resection [71].
Only pneumonectomy patients had mild postoperative pulmonary hypertension without
significant RV systolic dysfunction. Pulmonary embolism and cardiac herniation are rare
mechanisms that may cause RV dysfunction.
Left heart failure is generally a consequence of impaired right heart function, either by
decreasing left ventricular preload or by shifting the intraventricular septum resulting in a
decreased left ventricular volume. Other causes of left ventricular dysfunction are acute
myocardial infarction, pre-existing valvular disorders or cardiac herniation. [59]
5.7. Pulmonary oedema
Respiratory complications occur in 5-14% of patients [72]- [74]. The risk factors include age of
the patient, extent of resection, preoperative lung function and other co morbidities.
However, a number of case studies have described what appears to be a specific syndrome of
post pulmonary resection lung injury, which has been called post‐pneumonectomy pulmonary
edema (PPO). [75], [76], [77] The syndrome consisted of the onset of severe respiratory failure,
within 48 h of operation, associated with diffuse radiographic changes on plain chest films
consistent with pulmonary oedema. However, central pressure measurements showed no
evidence of left ventricular failure or cardiogenic pulmonary oedema. Its incidence is approx‐
imately 2.5% to 4% [78]- [83].
The mechanisms of injury are that ischaemia–reperfusion injury and [84] reactive oxygen
species. [85] Pulmonary capillary stress failure occurs when the pulmonary microvascular bed
is subjected to increased pressure and could produce capillary injury. [86]
Following are the recommendations and statements concerning fluid administration: (1) there
is no "third space" in the thorax, (2) total positive fluid balance in the first 24 hours should not
exceed 20 mL/kg, (3) a urinary output greater than 0.5 mL/kg/h is unnecessary, (4) the use of
invasive monitoring techniques is advisable if increased tissue perfusion is necessary postop‐
eratively, (5) factors that contribute to increased pulmonary venous pressures should be
minimized postoperatively, (6) hyperinflation of the residual lung should be avoided, (7)
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regular chest roentgenograms should be obtained postoperatively, (8) prolonged periods with
the residual lung in the dependent position should be avoided, and (9) prophylactic digitali‐
zation has not been shown to reduce the incidence of post resection supraventricular arrhyth‐
mias or of postpneumonectomy pulmonary edema. [59]
Therapy [59] consists of administration of diuretics, restriction of fluid, nutritional support,
and maintenance of adequate oxygenation, even with mechanical ventilation if necessary.
Despite aggressive treatment, the clinical outcome is poor with mortality exceeding 50%. Nitric
oxide ventilation and extracorporeal membrane oxygenation were tried as possible therapies.
In particular the use of inhaled nitric oxide, in doses of 10 to 20 ppm, was able to lower mortality
rates to 30% in a small series of patients. In the same report early intubation (at first signs of
ARDS), aspiration, bronchoscopy, and postural changes are also advocated.
Pulmonary hypertension is a major concern for patients undergoing general thoracic surgery
and often contraindicates pulmonary resection. Multiple aetiologies exist, such as cardiomy‐
opathy or intrinsic cardiac valvular disease, as well as destructive pulmonary parenchymal
processes resulting in cor pulmonale. The presence of pulmonary hypertension puts patients
at increased risk for anaesthesia and surgical morbidity.
5.8. Postpneumonectomy syndrome
Postpneumonectomy syndrome refers to bronchial compression occurring as a result of
massive mediastinal shift following pneumonectomy [87]- [89]. Incidence is approximately
one in 640 cases [90]. This syndrome is much more common after right pneumonectomy: the
mediastinum undergoes counterclockwise rotation as it shifts toward the pneumonectomy
space [87], [88], [90], [91], [92]. This results in stretching, distortion, and compression of the left
main bronchus between the pulmonary artery anteriorly and the aorta and vertebral column
posteriorly. The syndrome has also been described after left pneumonectomy, both in patients
with and without an aberrant right aortic arch [92], [94], [95], [96], [99]
Risk factors include young age and female sex [88], [97], [98]. These patients have more elastic
mediastinal tissues (thus prone to shifting) and a softer, more compliant airway (thus subject
to compression). [77] Patients typically present with exertional dyspnoea, stridor, and
recurrent pulmonary infection] within one year of pneumonectomy. The onset is usually
gradual, but acute obstruction may ensue in children. [99]
Airway stenting has been used in the treatment of inoperable patients and as a bridge to
surgery in cases of acute obstruction [95], [98]. Definitive treatment involves surgical reposi‐
tioning of the mediastinum in the midline. The mediastinum is then maintained in position by
a saline-filled silicone prosthesis which is inserted into the pneumonectomy space. [99]
5.9. Lobar torsion and gangrene
Lobar torsion represents a rotation of the bronchovascular pedicle with resultant airway
obstruction and vascular compromise. This disorder has been described in 3 different circum‐
stances: as a complication of thoracic surgery, after blunt trauma, and spontaneously [100]
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The overall incidence of lung torsion has been reported as 0.089%–0.2%, and is equally rare
after thoracic surgery. [100], [101]. The pathophysiological mechanisms of torsion develop‐
ment were previously postulated as an airless lobe, incision of the inferior pulmonary ligament,
pleural effusion, a long slim lobar pedicle, and lack of pleural adhesions. [100]
Patient’s condition manifests as high fever, severe chest pain, massive haemoptysis, bron‐
chorrhea, and sepsis, seen radiographically as abrupt consolidation and abnormal location of
the collapsed lung. Only meticulous observations of both clinical and radiological manifesta‐
tions, although uncharacteristic, can provide an indication of torsion development. [102].
Thereafter, bronchoscopy, contrast chest computed tomography, or angiography can be
diagnostic in finding the distorted or occluded bronchi or tapered pulmonary artery. [100],
[102]. Subsequent manoeuvres, such as contrast computed tomography, would have been
diagnostic and prompted reoperation. Intrathoracic bleeding was suspected considering the
history of extensive mediastinal adhesions, voluminous drainage, and blood loss. The
distinguishing features were: the chest opacity appeared hypertensive, and the resultant huge
tension markedly shifted the mediastinum; the serous fluid drainage, albeit a large amount,
was inconsistent with the severity of the anaemia; and radiographically, there was a convex
pulmonary margin around the chest tube. Wagner and Nesbitt stated that lobar torsion after
right upper lobe resections accounted for 70% of the cases in the literature, whereas 15%
followed resection of the left upper lobe. Torsion could happen in any lobe [103]
Options for surgical intervention include simple detorsion or resection of the involved
pulmonary segments. Detorsion alone is advocated only in patients who undergo re-inter‐
vention within a few hours of the primary procedure; while in the majority of patients,
pulmonary resection is mandatory due to pulmonary gangrene. Embolisms to other vital
organs are the main complications after surgery, which should therefore be carefully moni‐
tored. [102]
It seems reasonable to staple or suture the middle lobe to the lower lobe after a right upper
lobectomy if the oblique fissure is complete to prevent middle lobe torsion. Postoperatively,
the possibility of a lobar torsion after lobectomy should be considered when an infiltrate or
complete atelectasis persists or worsens; bronchoscopic intervention should be performed
promptly.
5.10. Cardiac tamponade
Pericardial tamponade, though rare after open lobectomy, should be considered along with
other complications when a patient repeatedly develops hypotension with therapies that
causes venodilation. A rising CVP and its equalization with pulmonary artery diastolic
pressure indicate cardiac tamponade. Symptoms include those related to cardiac tamponade:
low cardiac output and Beck's triad (hypotension, muffled heart sounds, and increased central
venous pressure). Diagnosis of this complication again requires a high index of suspicion.
Echocardiography is the diagnostic study of choice to visualize impaired filling of the right
ventricle because of increased pericardial pressure from the pericardial effusion.
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Treatment include an urgent pericardiocentesis as a temporizing measure followed by
reopening of the thoracotomy or a formal median sternotomy, which allows full inspection of
the interior of the pericardium and provides adequate access for definite management of the
cause. Minor injuries during retraction and dissection can produce life-threatening conditions
like pericardial tamponade. Episodes of unexplained hypotension suggest a cardiac aetiology;
a high index of suspicion and urgent surgical intervention can prevent adverse outcome.
5.11. Chylothorax
The thoracic duct can be injured during any thoracic procedure. Pleuro-pulmonary proce‐
dures, esophageal resection, intrapericardial and mediastinal procedures, and even less
invasive procedures like subclavian puncture may lead to thoracic duct injury and subsequent
chylothorax [104]- [108]. The incidence of chylothorax after pulmonary resection is between
0.7% and 2%. [109]- [110] This complication typically occurs at the time of resection. Aetiologies
in thoracic surgery include aggressive mediastinal lymph node dissection with incomplete
ligation of lymphatic channels or direct injury to the thoracic duct either during extra pleural
pneumonectomy or division of the pulmonary ligament. There will be loss of calories, fluids,
and proteins cause nutritional deficiency, dehydration, and immunologic dysfunction and if
not drained can cause respiratory compromise.
Chylothorax can compress the lung resulting in shortness of breath and respiratory distress.
Empyema is a rare complication due to the bacteriostatic nature of lecithin and fatty acids.
Sterile chyle does not cause pleuritic pain or a fibrotic inflammatory reaction. Loss of proteins
and vitamins, more than fat, leads to metabolic and nutritional defects, immunodeficiency,
coagulopathy, malnutrition and death. A prompt diagnosis and an accurate early treatment
are therefore essential. Analysis of the effusion demonstrates a triglyceride level >110 mg/dL
and a lymphocyte count >90%, gram, Sudan 3 stain, chylomicrins on electrophoresis. The total
protein concentration in the effusion is near or equal to the plasma protein concentration.
Leads to cardiopulmonary abnormalities and metabolic and immunologic
Mostly, it occurs from 2 days to 4 weeks postoperatively and varies from slight to severe forms
determined by the volume and rate of chyle loss. Conservative treatment initially involves
replacing the nutrients lost in the chyle and draining large chylothoraces using chest drain
insertion if necessary, to ensure complete lung expansion, nil by mouth or the administration
of low fat medium chain triglycerides by mouth. Medium chain triglycerides are directly
absorbed in to the portal system, bypassing the intestinal lymph system. This reduces the flow
of chyle in the thoracic duct allowing it the opportunity to heal. [111] If the chyle leak does not
stop following the use of medium chain triglycerides, then total parenteral feeding to reduce
the chyle flow even further should be considered. [111]- [112] Somatostatin and octreotide have
proved to be useful in the conservative treatment of chylothorax. These agents reduce intestinal
chyle production, thereby reducing the volume flowing through the injured thoracic duct.
[113]- [115]
Chemical pleurodesis with TALC is an alternative option in the majority of patients that are
too unwell for surgical closure of the chyle leak. A cannulation and embolisation technique
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prospectively to treat chylothorax was curative in patients’ with demonstratable duct leakage
[115] however reproducibility and success have varied in different centres. Surgical therapy
[115] is recommended in cases where despite conservative management the patient drains
more than 1.5 l/day in an adult or >100 ml/kg body weight per day in a child, leaks chyle at a
rate of >1 l/day for5 days or has persistent chyle flow for more than 2 weeks. Surgery is also
recommended if there has been a rapid decline in nutritional status despite conservative
management. Thoracic duct ligation can be performed during thoracotomy or by thoraco‐
scopic intervention. [116], [117] The main problem is identifying the chyle leak. Ligation of the
thoracic duct is successful in 90% of patients when performed just above the right hemi-
diaphragm. [118] Ligating here, also has the advantage of halting flow from any unidentified
accessory ducts. Collateral circulation redirects the chyle around the ligation point ensuring
that the chyle still completes its journey to the circulation. In cases of loculated or complicated
chylothorax pleural decortication with pleurodesis may be performed. [115]
5.12. Prolonged air leak
One of the common problems after thoracic surgery is prolonged postoperative air leak. Not
all patients have an air leak after pulmonary resection. However, many patients having a
lobectomy, segmentectomy, or a complicated wedge resection will leave the operating room
with a leak
The vast majority of postoperative air leaks, however, are alveolar air leaks, and therefore
initial management should be aimed at treating this entity. The management of bronchopleural
fistulas is substantially different than that of alveolar air leaks, often requiring early surgical
intervention. [119]
Air leaks that persist beyond a certain point may prolong the hospital length of stay. The
Society of Thoracic Surgeons database mentions air leaks are those which are typically present
when the patient could otherwise be discharged were it not for a continued air leak. The STS
Thoracic Surgery Database defined prolonged air leak as lasting >5 days. Prolonged air leak
may be associated with an increased complication rate and certainly may increase length of
stay. Okereke et al. [120] found complications in up to 30% for patients with any air leak but
only 18% in patients without, but this may have been a marker of extent of surgery or disease.
Varela and colleagues [121] found that air leak lasting at least 5 days was associated with
greater pulmonary morbidity, such as atelectasis, pneumonia, and empyema. They also found
that the length of stay was extended by 6 days. Most leaks will stop within 2 to 3 weeks
By far the most common treatment of airleaks is watchful waiting with continuous drain‐
age through a tube thoracostomy. More than 90% of air leaks seemed to stop within sev‐
eral  weeks  after  operation  with  this  form  of  management  alone,  with  only  rare
development of an empyema. [119]A valved, outpatient system, such as a Heimlich, can
only  be  considered  in  patients  who  have  no  more  than  a  small,  stable,  asymptomatic
pneumothorax on water seal. [119]
Blood patch or chemical pleurodesis may be considered as the next step. Experience with these
techniques is variable. The instillation of sclerosing materials into the pleural space through
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the thoracostomy tube promotes symphysis of visceral and parietal pleura and may produce
leak closure. Given the low rate of infection reported in published series, it remains unclear
whether antibiotics should routinely be used. [119]
Autologous blood patch is another nonsurgical option to treat PAL after the operation or
spontaneous pneumothorax [122]- [127]. To summarize, blood-patch pleurodesis involves the
instillation of autologous blood into the pleural space through a chest catheter. It is simple,
relatively painless, and often effective, but some information suggests that blood-patch
pleurodesis may also carry an increased risk of intrathoracic infection. Although there are six
articles on this subject, it is difficult to draw definitive conclusions due to the variable study
sizes (from 2 patients to 32 patients), quantity of blood injected (50 to 150 mL), and endpoint
definitions.
Pneumoperitoneum instilled through a transabdominal catheter has been reported to be
effective in some cases [128], [129]. Surgical options to accomplish pleural symphysis or control
the source of an alveolar air leak, or both, include video-assisted thoracic surgery (VATS) with
parenchymal stapling, VATS with chemical pleurodesis, VATS with pleural abrasion [130],
[131], VATS with application of topical sealants [132], [133], and the less well-supported use
of VATS with laser sealing of the site of leak [134]. Omental or muscle flaps placed at re-
thoracotomy can also be used successfully to obliterate the pleural space in patients with
incomplete lung expansion and residual air leaks [135].
6. Injuries to surrounding structures
Injuries can happen to the oesophagus, phrenic nerve, recurrent laryngeal nerve, dural
lacerations and spinal cord injury and peripheral embolisation of tumour.
6.1. Injury to the phrenic nerve
Thoracic  surgical  procedures  can  produce  phrenic  nerve  injury.  It  happens  when  there
are adhesions or in redo surgeries. Surgeries like anterior mediastinal tumor excision, re‐
section of superior sulcus tumours, repair of thoracic outlet syndrome, or right-sided me‐
diastinal  lymph node dissection could all  cause phrenic nerve injury.  Such injuries may
be temporary or permanent.  Presenting features are shortness of breath on exertion and
impaired exercise tolerance [136].  If  patients are on a ventilator then there may be diffi‐
culty  in  weaning  of  ventilator.  X-ray  shows  elevation  of  the  affected  hemi  diaphragm.
This is  confirmed by ultrasound or fluoroscopy, which is the diagnostic study of choice
in evaluation of these injuries. The best method of management of unilateral palsy is dia‐
phragmatic plication [136].
6.2. Injury to the recurrent laryngeal nerve
Injury to the recurrent laryngeal nerve generally present in the postoperative phase with
a weak hoarse and whispery voice. They nay describe a voice, which gets weaker as the
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day progresses,  which may cause aspiration or  impaired physiotherapy due to inability
to cough effectively.  A laryngoscopy is  done to confirm the diagnosis and adduction of
the affected vocal cord or sluggish motion will be absent. Treatment depends on whether
the injury is temporary or permanent. A fibre optic evaluation is necessary to test swal‐
lowing and sensation.  To assist  with pulmonary physiotherapy and decrease the risk of
aspiration,  medialization laryngoplasty may be suggested [136].  This  can be done as  an
office  procedure  with  the  aid  of  autologous  fat,  Gel  foam,  collagen,  or  polytetrafluoro‐
ethylene. [136]
7. Infections
Infectious complications after pulmonary surgery include operative wound infection, em‐
pyema,  and  nosocomial  pneumonia.  Antibiotic  prophylaxis  should  therefore  be  guided
against these three entities. The incidence varies from 5% to 24.4%. They are responsible
for increased hospital mortality to up to 19% as well as increased costs and length of hos‐
pital stay. In one study 53.6% of the germs identified were gram-negative bacteria, 39.3%
gram-positive bacteria, and 7.1% were fungi [137]. These infections should be aggressive‐
ly  treated  with  appropriate  antibiotics  after  culture.  Chest  physiotherapy,  pain  control,
bronchodilators,  and early  ambulation should be done for  all  patients  but  regardless  of
these  pneumonia  develops.  Postoperative  atelectasis  after  pulmonary surgery  should be
aggressively managed before it deteriorates into pneumonia. Our policy is to give Ticar‐
cillin  Sodium and Potassium Clavulanate  3.1  g  four times a  day in divided doses till  a
positive culture is obtained.
The incidence of empyema is dropping but could happen if there is prolonged air leak.
Generally they are managed with antibiotics but may necessitate thoracotomy and wash out.
Other complications include pulmonary embolism, deep venous thrombosis, renal failure,
strokes, major gastrointestinal bleed and late empyema. These complications should be
recognised very early and aggressive management should be instituted if they are to be tackled
successfully.
Thus postoperative care and management of postoperative complications is a team approach
and good preoperative and intraoperative measures minimize the incidence of postoperative
complications and early recognition and treatment is essential for successful outcomes.
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